Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia

Table 4

Patients who experienced adverse events that led to premature discontinuation from the study.

Subject	Age/sex	Event	Severity	Causality
FCM
1	28/F	Injection site reaction	Grade 2	Probable
2	56/M	Systemic inflammatory response syndrome	Grade 3	Probable
3	76/M	Death	Grade 5	Unlikely
4	53/M	Colon cancer recurrent	Grade 4	None
DEX
1	81/M	Dyspnea	Grade 4	Probable
2	19/F	Abdominal pain	Grade 1	Probable
3	29/F	Hypersensitivity	Grade 2	Probable
4	21/F	Hypersensitivity	Grade 2	Probable
5	57/F	Hypersensitivity	Grade 2	Probable
6	45/M	Hypersensitivity	Grade 3	Probable
7	37/F	Peripheral edema	Grade 3	Probable
8	32/F	Hypersensitivity	Grade 4	Probable
9	18/F	Dyspnea	Grade 1	Probable
10	64/F	Anaphylactic reaction	Grade 4	Probable
11	20/F	Hypersensitivity	Grade 3	Probable